A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy. - Gambaro, Karen; Marques, Maud; McNamara, Suzan; Couetoux du Tertre, Mathilde; Hoffert, Cyrla; Srivastava, Archana; Schab, Anna; Alcindor, Thierry; Langleben, Adrian; Sideris, Lucas; Abdelsalam, Mahmoud; Tehfe, Mustapha; et al. (International Journal of Molecular Sciences, 2024)